HB-adMSCs for the Treatment of Crohn's Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Crohn Disease (CD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hope Biosciences Research Foundation, Sugar Land, Texas, United States
Contact: Study coordinator (David Gonzalez, RN) · david@hopebio.org · 346-900-0340
Contact: Principal Investigator (Thanh Cheng, MD)

Study leads

Thanh Cheng, MD
Principal Investigator
Hope Biosciences Research Foundation

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Crohn Disease (CD)

Abroad (travel likely)RecruitingPHASE2

Beverly Hills, United States · St Louis, United States

Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease

Crohn Disease (CD)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Marseille, France

Autologous Stem Cell Transplant for Crohn's Disease

Crohn Disease

Abroad (travel likely)RecruitingPHASE2

New York, United States

Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease

Ulcerative Colitis (UC) · Crohn Disease (CD)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Groningen, Netherlands